These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 37185389)

  • 21. Patient initiated follow up after gynaecological malignancy: National survey of current UK practice.
    Coleman L; Newton C
    Eur J Obstet Gynecol Reprod Biol; 2020 May; 248():193-197. PubMed ID: 32240892
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Protocol of a randomized controlled trial of the fear of recurrence therapy (FORT) intervention for women with breast or gynecological cancer.
    Maheu C; Lebel S; Courbasson C; Lefebvre M; Singh M; Bernstein LJ; Muraca L; Benea A; Jolicoeur L; Harris C; Ramanakumar AV; Ferguson S; Sidani S
    BMC Cancer; 2016 Apr; 16():291. PubMed ID: 27112319
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Exploring the views of patients' and their family about patient-initiated follow-up in head and neck cancer: A mixed methods study.
    Lorenc A; Greaves C; Duda J; Brett J; Matheson L; Fulton-Lieuw T; Secher D; Rhodes P; Ozakinci G; Nankivell P; Mehanna H; Jepson M;
    Eur J Cancer Care (Engl); 2022 Nov; 31(6):e13641. PubMed ID: 35789510
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Follow-up strategies following completion of primary cancer treatment in adult cancer survivors.
    Høeg BL; Bidstrup PE; Karlsen RV; Friberg AS; Albieri V; Dalton SO; Saltbæk L; Andersen KK; Horsboel TA; Johansen C
    Cochrane Database Syst Rev; 2019 Nov; 2019(11):. PubMed ID: 31750936
    [TBL] [Abstract][Full Text] [Related]  

  • 25. ePRO-based individual follow-up care for women treated for early breast cancer: impact on service use and workflows.
    Riis CL; Stie M; Bechmann T; Jensen PT; Coulter A; Möller S; Steffensen KD
    J Cancer Surviv; 2021 Aug; 15(4):485-496. PubMed ID: 33415653
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Exploring the acceptability and feasibility of patient-initiated follow-up for women treated for stage I endometrial cancer.
    Beaver K; Martin-Hirsch P; Williamson S; Kyrgiou M
    Eur J Oncol Nurs; 2020 Feb; 44():101704. PubMed ID: 31812918
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Fear of recurrence among older breast, ovarian, endometrial, and colorectal cancer survivors: Findings from the WHI LILAC study.
    Krok-Schoen JL; Naughton MJ; Bernardo BM; Young GS; Paskett ED
    Psychooncology; 2018 Jul; 27(7):1810-1815. PubMed ID: 29644766
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Medical, demographic and psychological correlates of fear of cancer recurrence (FCR) morbidity in breast, colorectal and melanoma cancer survivors with probable clinically significant FCR seeking psychological treatment through the ConquerFear study.
    Smith A'; Sharpe L; Thewes B; Turner J; Gilchrist J; Fardell JE; Girgis A; Tesson S; Descallar J; Bell ML; Beith J; Butow P;
    Support Care Cancer; 2018 Dec; 26(12):4207-4216. PubMed ID: 29882025
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Fear of cancer recurrence and unmet needs among breast cancer survivors in the first five years. A cross-sectional study.
    Ellegaard MB; Grau C; Zachariae R; Bonde Jensen A
    Acta Oncol; 2017 Feb; 56(2):314-320. PubMed ID: 28093034
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Novel Clinician-Lead Intervention to Address Fear of Cancer Recurrence in Breast Cancer Survivors.
    Liu J; Butow P; Bui KT; Serafimovska A; Costa DSJ; Kiely BE; Hui MN; Goodwin A; McNeil CM; Beith JM
    JCO Oncol Pract; 2021 Jun; 17(6):e774-e784. PubMed ID: 33571035
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Long-term efficacy and cost-effectiveness of blended cognitive behavior therapy for high fear of recurrence in breast, prostate and colorectal Cancer survivors: follow-up of the SWORD randomized controlled trial.
    Burm R; Thewes B; Rodwell L; Kievit W; Speckens A; van de Wal M; Prins J
    BMC Cancer; 2019 May; 19(1):462. PubMed ID: 31096934
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Acceptance and commitment therapy for breast cancer survivors with fear of cancer recurrence: A 3-arm pilot randomized controlled trial.
    Johns SA; Stutz PV; Talib TL; Cohee AA; Beck-Coon KA; Brown LF; Wilhelm LR; Monahan PO; LaPradd ML; Champion VL; Miller KD; Giesler RB
    Cancer; 2020 Jan; 126(1):211-218. PubMed ID: 31539169
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Fear of cancer recurrence and disease progression in long-term prostate cancer survivors after radical prostatectomy: A longitudinal study.
    Meissner VH; Olze L; Schiele S; Ankerst DP; Jahnen M; Gschwend JE; Herkommer K; Dinkel A
    Cancer; 2021 Nov; 127(22):4287-4295. PubMed ID: 34358337
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Association between information provision and supportive care needs among ovarian cancer survivors: A cross-sectional study from the PROFILES registry.
    Rietveld MJA; Husson O; Vos MCC; van de Poll-Franse LV; Ottevanger PBN; Ezendam NPM
    Psychooncology; 2018 Aug; 27(8):1922-1929. PubMed ID: 29683231
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Exploring socio-demographic, physical, psychological, and quality of life-related factors related with fear of cancer recurrence in stomach cancer survivors: a cross-sectional study.
    Shin J; Shin DW; Lee J; Hwang J; Lee JE; Cho B; Song YM
    BMC Cancer; 2022 Apr; 22(1):414. PubMed ID: 35428224
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Revision of the fear of cancer recurrence cognitive and emotional model by Lee-Jones et al with women with breast cancer.
    Maheu C; Hébert M; Louli J; Yao TR; Lambert S; Cooke A; Black A; Kyriacou J
    Cancer Rep (Hoboken); 2019 Aug; 2(4):e1172. PubMed ID: 32721129
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Acceptability and utilisation of patient-initiated follow-up for endometrial cancer amongst women from diverse ethnic and social backgrounds: A mixed methods study.
    Kumarakulasingam P; McDermott H; Patel N; Boutler L; Tincello DG; Peel D; Moss EL
    Eur J Cancer Care (Engl); 2019 Mar; 28(2):e12997. PubMed ID: 30748056
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Examining Predictors of Fear of Cancer Recurrence Using Leventhal's Commonsense Model: Distinct Implications for Oncology Nurses.
    Galica J; Maheu C; Brennenstuhl S; Townsley C; Metcalfe K
    Cancer Nurs; 2021; 44(1):3-12. PubMed ID: 31868820
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Protocol of an implementation study of a clinician intervention to reduce fear of recurrence in cancer survivors (CIFeR_2 implementation study).
    Liu J; Serafimovska A; He S; Butow P; Shaw J; McHardy CJ; Harris G; Butt Z; Beith J
    BMC Med Educ; 2023 May; 23(1):312. PubMed ID: 37147706
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Assessment of quality of life, information, and supportive care needs in patients with muscle and non-muscle invasive bladder cancer across the illness trajectory.
    Chung J; Kulkarni GS; Morash R; Matthew A; Papadakos J; Breau RH; Guttman D; Bender J; Jones JM
    Support Care Cancer; 2019 Oct; 27(10):3877-3885. PubMed ID: 30767131
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.